XML 32 R16.htm IDEA: XBRL DOCUMENT v3.24.4
Note 8 - Stockholders' Equity
12 Months Ended
Nov. 30, 2024
Notes to Financial Statements  
Equity [Text Block]

Note 8: Stockholders' Equity

 

Preferred Stock

 

The Board of Directors is authorized to issue up to 10,045,900 shares of preferred stock that may be issued in one or more series and with such stated value and terms as the Board of Directors may determine.

 

Common Stock

 

There were 160,000,000 shares of common stock with a par value of $1.00 authorized and 54,657,103 and 54,092,987 shares issued and outstanding at November 30, 2024 and December 2, 2023, respectively.

 

On April 22 2022, the Board of Directors authorized a share repurchase program of up to $300,000 of our outstanding common shares for a period of up to five years. Under the program, we are authorized to repurchase shares for cash on the open market, from time to time, in privately negotiated transactions or block transactions, or through an accelerated repurchase agreement. The timing of such repurchases is dependent on price, market conditions and applicable regulatory requirements. Upon repurchase of the shares, we reduce our common stock for the par value of the shares with the excess being applied against additional paid-in capital. We repurchased shares under this program with an aggregate value of $31,811 during 2024. We did not repurchase any shares during 2023 and 2022 under our share repurchase program. Up to $268,000 of our outstanding common shares may still be repurchased under the current share repurchase program.

 

Common Shares Outstanding

 

2024

  

2023

  

2022

 

Beginning balance

  54,092,987   53,676,576   52,777,753 

Stock options exercised

  746,892   314,832   657,789 

Deferred compensation paid

  20,691   102,108   118,429 

Restricted units vested

  297,035   113,339   172,474 

Shares withheld for taxes

  (93,102)  (113,868)  (49,869)

Share repurchases

  (407,400)  -   - 

Ending balance

  54,657,103   54,092,987   53,676,576 

 

Dividends declared per common share were $0.856 and $0.805 for the year ended  November 30, 2024 and December 2, 2023, respectively.